𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of estramustine phosphate (Estracyt®) in prostatic cancer patients

✍ Scribed by P. O. Gunnarsson; S. -B. Andersson; S. -Å. Johansson; T. Nilsson; G. Plym-Forshell

Publisher
Springer
Year
1984
Tongue
English
Weight
732 KB
Volume
26
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estramustine phosphate (estracyt) follow
Estramustine phosphate (estracyt) following androgens in men with refractory stage D2 prostate cancer
✍ Francesco Boccardo; Andrea Decensi; Domenico Guarneri; Giuseppe Martorana; Claud 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 331 KB

Twenty-two orchiectomized men with progressive stage D2 prostate cancer were treated with a 3-week cycle of estramustine phosphate (EMP: from day 3 to day 21) and androgen priming (from day 1 to day 4). A partial response according to the NPCP-USA criteria was shown in 4 of 20 evaluable patients. Me

Pharmacokinetics and testosterone suppre
Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin®) in prostatic cancer patients
✍ Stege, Reinhard; Gunnarsson, Per Olov; Johansson, Carl-Johan; Olsson, Per; Pouse 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB

The pharmacokinetics and endocrine effects of polyestradiol phosphate (PEP; EstradurinQD) were studied by determination of the concentrations of estradiol (EJ, unconjugated (El) and total estrone (tE,; 285% estrone sulfate), and testosterone in serum from 11 prostatic cancer patients after administr

Radioiodinated estramustine phosphate an
Radioiodinated estramustine phosphate and estramustine binding protein Antibody accumulate in the prostate of a mouse
✍ Stålberg, Kaarlo; Kairemo, Kalevi; Karonen, Sirkka-Liisa; Jekunen, Antti; Taari, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

## Background: The purpose of this study was to determine the distribution of radioiodinated estramustine (ri-emp) and a radioiodinated antibody against estramustine binding protein (ri-embp-ab) in mice. ## Methods: Ri-emp and ri-embp-ab were injected in male mice intravenously, and the activitie

Clinical experience with intravenous est
Clinical experience with intravenous estramustine phosphate, paclitaxel, and carboplatin in patients with castrate, metastatic prostate adenocarcinoma
✍ David B. Solit; Michael Morris; Susan Slovin; Tracy Curley; Lawrence Schwartz; S 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

## Abstract ## BACKGROUND The combination of paclitaxel, oral estramustine phosphate (EMP), and carboplatin (TEC) has shown antitumor activity in patients with castrate, metastatic prostate carcinoma. To improve the therapeutic efficacy and reduce the toxicity of TEC, the authors substituted intra